An adult with attention deficit hyperactivity disorder (ADHD) presents to a physician. To date no behavioral or drug interventions have proven useful. The physician has just read several reports about a drug that is approved and marketed for another indication but has shown some benefit for ADHD. The physician wants to prescribe this drug in the labeled marketed dose for the individual patient. Which of the following would be the most appropriate course of action?

Quesiton : An adult with attention deficit hyperactivity disorder (ADHD) presents to a physician. To date no behavioral or drug interventions have proven useful. The physician has just read several reports about a drug that is approved and marketed for another indication but has shown some benefit for ADHD. The physician wants to prescribe this drug in the labeled marketed dose for the individual patient. Which of the following would be the most appropriate course of action?

Answer: Treat the patient with the drug based on physician's best medical judgment

Most relevent text from all around web: An adult with attention deficit hyperactivity disorder (ADHD) presents to a physician. To date no behavioral or drug interventions have proven useful. The physician has just read several reports about a drug that is approved and marketed for another indication but has shown some benefit for ADHD. The physician wants to prescribe this drug in the labeled marketed dose for the individual patient. Which of the following would be the most appropriate course of action? To date no behavioral or drug interventions have proven useful . The physician has just read several reports about a drug that is approved and marketed for another indication but has shown some benefit for ADHD . The physician wants to prescribe this drug in the labeled marketed dose for the individual patient . An adult with attention deficit hyperactivity disorder ( ADHD ) presents to a physician . To date no behavioral or drug interventions have proven useful . The physician has just read several reports about a drug that is approved and marketed for another indication but has shown some benefit for ADHD . The physician wants to prescribe this drug in ... TY - JOUR. T1 - Assessment of physician practices in adult attention-deficit/hyperactivity disorder . AU - Goodman David. AU - Surman Craig Bruce difficulty distinguishing ADHD from other disorders as a barrier to diagnosis this was the most frequently reported barrier for ADHD management by both groups (53% for … INTRODUCTION. Attention deficit hyperactivity disorder ( ADHD ) one of the most common neuropsychiatric disorders of childhood and adolescence often per...